AI’s Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

The AI in Business Podcast

English - November 07, 2023 07:00 - 19 minutes - 17.6 MB - ★★★★ - 101 ratings
Technology Business Management artificial digital data intelligence learning machine science transformation Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: How to Think of the Future of Finserv in the Age of GenAI - with Marco Argenti of Goldman Sachs

Next Episode: New Approaches to AI in Patient Experiences - with Dan Buckland of Duke University Health Systems

Today’s guest is Ramesh Durvasula, Senior Vice President of R&D IT at Lilly. Ramesh joins us on the program today to discuss AI’s impact on the drug targeting process, particularly in helping pharmaceutical leaders like Lilly better predict what potential drugs to invest in for bringing to market and when. With increased certainty in drug targeting, Ramesh explains how AI capabilities are driving clinical trials to be used as an alternative form of healthcare. Visit emerj.com/beg1 to learn more about the practical steps for AI deployment for non-technical professionals.